New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays

Transfusion - Tập 38 Số 1 - Trang 56-59 - 1998
J.M. Jongerius, MR Wester1, H. T. M. Cuypers, W.R. van Oostendorp2, P.N. Lelie3, C.L. van der Poel4, E F van Leeuwen5
1Viral Diagnostic Laboratory, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, the Netherlands.
2Head, Donor Affairs, Red Cross Blood Bank, Midden-Nederland.
3Head, Viral Diagnostic Laboratory, Central Laboratory of the Netherlands Red Cross Blood Transfusion Service.
4Transfusion Medicine, and Epidemiologist, Red Cross Blood Bank, Midden-Nederland.
5Red Cross Blood Bank, Midden-Nederland.

Tóm tắt

BACKGROUND: Envelope mutant forms of hepatitis B virus (HBV), impairing HBV antibody recognition, have been reported with mutations in single or multiple sites of the hepatitis B surface antigen (HBsAg) group‐ specific “a” determinant. Blood donors infected with such an HBsAg mutant form of HBV may escape detection by HBsAg screening assays and therefore may affect the safety of the blood supply. CASE REPORT: A repeat blood donor became HBsAg‐reactive in an enzyme immunoassay. Confirmatory testing yielded negative results for HBsAg in a radioimmunoassay and in four enzyme immunoassays used in blood donor screening. The specificity of the HBsAg reactivity in the first enzyme immunoassay was confirmed by HBsAg neutralization with antibody to HBsAg. Additional HBV confirmatory test results were positive for antibody to hepatitis B core antigen and antibody to hepatitis B e antigen; negative for antibody to HBsAg and for hepatitis B e antigen; and positive for HBV DNA. DNA sequence analysis of the “a” determinant region of HBsAg revealed amino acid substitutions from Q (Gln) to R (Arg) at codon 129 and from M (Met) to T (Thr) at codon 133. CONCLUSION: This case illustrates the presence of HBsAg mutant forms of HBV in a West European blood donor population that were undetected by several HBsAg screening assays. Adaptation of HBsAg screening is indicated to overcome deficiencies in sensitivity in detecting HBsAg mutant forms of HBV. Screening for antibody to hepatitis B core antigen or HBV DNA may also detect blood donors infected with HBsAg mutant forms of HBV

Từ khóa


Tài liệu tham khảo

10.1056/NEJM199606273342601

Jagodzinski L, 1994, Detection of hepatitis B viral sequences in early HBV infection, Transfusion, 34, 37S

McMahon BJ, 1981, Delayed development of antibody to hepatitis B surface antigen after symptomatic infection with hepatitis B virus, J Clin Microbiol, 14, 130, 10.1128/jcm.14.2.130-134.1981

10.1056/NEJM198501313120503

10.1007/978-4-431-68255-4_61

10.1016/0140-6736(90)91874-A

10.1002/(SICI)1099-1654(199603)6:1<25::AID-RMV162>3.0.CO;2-2

10.7326/0003-4819-104-4-488

10.1016/S0140-6736(95)91153-7

10.1046/j.1537-2995.1995.35195090661.x

1995, NIH consensus statement on infectious disease testing for blood transfusion

10.1172/JCI114308

10.1099/0022-1317-74-7-1341

10.1016/S0140-6736(95)92599-6

10.1172/JCI116148

10.1046/j.1423-0410.1997.7240199.x

Thông tin
Thông tin xuất bản

Transfusion

Tập 38 Số 1

56-59

Thông tin tác giả